Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Arthroplasty. 2013 Jun 12;29(2):308–313. doi: 10.1016/j.arth.2013.05.008

Table 4.

presents results from the multivariate regression, odds rations and 95% Wald confidence limits

Multivariate Regression: Rheumatoid Arthritis vs. Osteoarthritis (Reference)
Effect Adjusted Odds Ratio 95% Confidence Limit P-Value
Cumulative Adverse events 0.98 0.92 1.05 0.63
Mechanical Ventilation 0.91 0.70 1.19 0.49
Blood Product Transfusion 1.51 1.44 1.59 <0.001
Prolonged Hospitalization 1.10 1.05 1.15 <0.001
Increased Cost of Hospitalization 1.16 1.11 1.21 <0.001

Reference = 1 (Osteoarthritis). Cumulative adverse event occurrence is defined by occurrence of any of the following: pulmonary embolism, deep venous thrombosis, cerebrovascular event, pulmonary compromise, sepsis, cardiac adverse events including myocardial infarction, pneumonia, all other infections, acute renal failure, gastrointestinal adverse events and in-hospital mortality